NETHYLPHENIDATE AND ADHD: INFLUENCE OF AGE, IQ AND NEURODEVELOPMENTAL STATUS
I tiakina i:
MAYES, S.D., ET AL., NETHYLPHENIDATE AND ADHD: INFLUENCE OF AGE, IQ AND NEURODEVELOPMENTAL STATUS. DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, Vol. 36, no. 12 (1994), p. 1099-1107.
Ref.
46285
Tauwāhi:
SIIS R.727
Palabras clave:
Discapacidad, Discapacidad intelectual, Fármacos, Trastornos de atención
Discapacidad, Discapacidad intelectual, Fármacos, Trastornos de atención
Ngā tūemi rite: NETHYLPHENIDATE AND ADHD: INFLUENCE OF AGE, IQ AND NEURODEVELOPMENTAL STATUS
- WHY CHILDREN WITH ADHD DO NOT HAVE LOW IQs
- FENFLURAMINE AND METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND BORDELINE IQ: CLINICAL EFFECTS
- EFFECTS AND NONEFFECTS OF METHYLPHENIDATE IN CHILDREN WITH MENTAL RETARDATION AND ADHD
- ASSOCIATION OF SEROTONIN CONCENTRATION TO BEHAVIOR AND IQ IN AUTISTIC CHILDREN
- ADHD SUBTYPES AND CO-OCCURRING ANXIETY, DEPRESSION, AND OPPOSITIONAL-DEFIANT DISORDER
- PHARMACOTHERAPY IN ADULTS WITH ADHD